Skip to content
1932

Women’s Health

Studies of migraine’s many triggers offer paths to new therapies

One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building about a slew of additional drug targets.

Why a diabetes drug fell short of anticancer hopes

Population and animal studies suggested it could treat cancer, but the clinical trials were a bust. Here’s what happened and what potential may remain.

To pee or not to pee? That is a question for the bladder — and the brain

How do we sense the need to urinate? The basic urge is surprisingly complex and can go awry as we age.

The untapped potential of stem cells in menstrual blood

Long overlooked, menstrual stem cells could have important medical applications, including diagnosing endometriosis

Genes and heart disease: Finally making the link

Polygenic risk scores — a patient’s chance, based on tiny DNA variants, of developing cardiovascular disease, breast cancer and more — are coming to clinics. But there are kinks to iron out and accuracy remains an issue.

New noninvasive RNA tests could help identify at-risk pregnancies

The next wave of prenatal screening looks for fragments of RNA within the blood to flag risk of preeclampsia and preterm labor

America is failing women’s health

OPINION: Systemic inequity means women in the US die younger and suffer more than they should. It’s time for health for all.

When depression sneaks up on menopause

Fluctuating levels of estrogen during a period known as perimenopause can wreak havoc on the mental health of women in midlife. Diagnosis and treatment have been elusive despite symptoms as serious as suicidal thoughts.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error